Skip to main content
Log in

The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients

Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24 h, 48 h, 72 h, 96 h, and 120 h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28 days was also recorded. After 24 h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72 h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (P < 0.01). From 72 to 120 h of CBP treatment, oliguria was resolved in 24 patients, with improved sensitivity to diuretics. The fatality rate at 28 days was 11.12 %. CBP treatment could improve myocardial function, shorten the oliguria period, decrease the fatality rate, and improve the prognosis of CRS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Du, Y., Li, X., & Liu, B. (2014). Advances in pathogenesis and current therapeutic strategies for CRS. Life Sciences, 99(1–2), 1–6.

    Article  CAS  PubMed  Google Scholar 

  2. Kociol, R., Rogers, J., & Shaw, A. (2009). Organ cross talk in the critically ill: the heart and kidney. Blood Purification, 27(4), 311–320.

    Article  PubMed  Google Scholar 

  3. Lindner, G., Doberer, E., Vychytil, A., et al. (2009). Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis. Wiener klinische Wochenschrift, 121(11–12), 391–397.

    Article  CAS  PubMed  Google Scholar 

  4. Li, X., Mao, H., Yu, X., et al. (2014). Prognostic factors in continuous hemofiltration therapy for patients with CRS. Blood Purification, 37(2), 99–105.

    Article  PubMed  Google Scholar 

  5. Ricci, Z., & Ronco, C. (2012). Renal replacement therapy in the critically ill:getting it right. Current Opinion in Critical Care, 18(6), 607–612.

    Article  PubMed  Google Scholar 

  6. Lee, P. T., Lin, H. H., Jiang, S. T., et al. (2010). Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Stem Cells, 28(3), 573–584.

    CAS  PubMed  Google Scholar 

  7. Dunlay, S. M., Pereira, N. L., & Kushwaha, S. S. (2014). Contemporary strategies in the diagnosis and management of heart failure. Mayo Clinic Proceedings, 89(5), 662–676.

    Article  PubMed  Google Scholar 

  8. Ronco, C. (2005). Acute Dialysis Quality Initiative (ADQI): the PASSPORT project. International Journal of Artificial Organs, 28(5), 438–440.

    CAS  PubMed  Google Scholar 

  9. Fieghen, H., Wald, R., & Jaber, B. L. (2009). Renal replacement therapy for AKI. Nephron Clinical Practice, 112(4), c222–c229.

    Article  PubMed  Google Scholar 

  10. Ronco, C., Chionh, C. Y., Haapio, M., Anavekar, N. S., House, A., & Bellomo, R. (2009). The cardiorenal syndrome. Blood Purification, 27(1), 114–126.

    Article  PubMed  Google Scholar 

  11. Shlipak, M. G. (2003). Pharmacotherapy for heart failure in patients with renal insufficiency. Annals of Internal Medicine, 138(11), 917–924.

    Article  CAS  PubMed  Google Scholar 

  12. Jarnberg, P. O. (2004). Renal protection strategies in the perioperative period. Best Practice & Research Clinical Anaesthesiology, 18(4), 645–660.

    Article  Google Scholar 

  13. Wago, M., & Shimooka, T. (2011). Extracorporeal blood purification (renal replacement therapy). Nihon Rinsho, 69(3), 534–540.

    PubMed  Google Scholar 

  14. Kaltenmaier, B., Pommer, W., Kaufmann, F., Hennig, E., Molzahn, M., & Hetzer, R. (2000). Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO Journal, 46(3), 330–333.

    Article  CAS  PubMed  Google Scholar 

  15. Jang, H. R., Gandolfo, M. T., Ko, G. J., Satpute, S. R., Racusen, L., & Rabb, H. (2010). B cells limit repair after ischemic AKI. Journal of the American Society of Nephrology, 21(4), 654–665.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

Authors claim to have no financial conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianzhong Meng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jia, F., Rong, P., Li, D. et al. The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients. Cell Biochem Biophys 71, 957–961 (2015). https://doi.org/10.1007/s12013-014-0293-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-014-0293-x

Keywords

Navigation